Moneycontrol PRO
HomeNewsIndiaNo tests needed for contacts of COVID-19 patients, domestic travellers, says ICMR in new guidelines

No tests needed for contacts of COVID-19 patients, domestic travellers, says ICMR in new guidelines

For in-hospital settings, the ICMR categorically noted that "no emergency procedure (including surgeries and deliveries) should be delayed for lack of a test."

January 10, 2022 / 20:29 IST
Representative image

Contacts of persons infected with COVID-19, unless if they are at high-risk, are not required to be tested for the contagious disease, the Indian Council of Medical Research (ICMR) said in its latest guidelines released on January 10.

Individuals undertaking inter-state domestic travel are also not required to be tested, the top medical body said.

The ICMR has also exempted asymptomatic individuals in community settings, along with patients who stand discharged as per home isolation guidelines, from the COVID-19 tests.

"Patients being discharged from a COVID-19 facility as per revised discharge policy" are also included in the list of people who need not be tested.

Track coronavirus-related news and live updates

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

For in-hospital settings, the ICMR categorically noted that "no emergency procedure (including surgeries and deliveries) should be delayed for lack of a test."

Patients should not be referred to other facilities for lack of a testing facility, it added.

All arrangements should be made to collect and transfer samples to testing facilities, mapped to the health facility, the medical body said.

"Asymptomatic patients undergoing surgical / non-surgical invasive procedures including pregnant women in/near labour who are hospitalized for delivery should not be tested unless warranted or symptoms develop," the guidelines clarified.

The ICMR also noted that admitted patients may not be tested more than once a week.

Among individuals who are to be tested, as per the guidelines, including individuals who are showing symptoms of "cough, fever, sore throat, loss of taste and/or smell, breathlessness and/or other respiratory symptoms"

At-risk contacts of laboratory-confirmed cases may also be tested on a priority basis. The at-risk category includes senior citizens aged above 60 and individuals suffering from co-morbidity such as diabetes,
hypertension, chronic lung or kidney disease, malignancy, and obesity, etc.

Tests are to be conducted on individuals undertaking international travel (as per country-specific requirements) and international travelers arriving at Indian airports/seaports/ports of entries as per laid down
guidelines, it added.

The ICMR directive comes amid increasing pressure on testing labs across the nation. A total of 13.52 lakh tests were conducted across the country on January 9.

The testing capacity is likely to be increased in metropolitan cities where the COVID-19 positivity rate has soared over the past two weeks. In Delhi and Mumbai, the infection rate has surged past 20 percent. Across India, a total of 1.79 lakh infections were reported on January 10 at a positivity rate of 13.29 percent.

Moneycontrol News
first published: Jan 10, 2022 08:29 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347